DexTech Medical Holds Annual General Meeting

• DexTech Medical shareholders approved no dividend for fiscal 2025/2026 at the annual general meeting on November 2, 2026.
• Shareholders adopted the income statement and balance sheet, approving the board's proposed allocation of the company's result.
• The meeting discharged board members and the CEO from liability.
• All five directors were re-elected, with Andreas Segerros as chairman; shareholders approved no deputy directors.
• Azets Revision & Rådgivning was appointed auditor until the next annual general meeting, with Per Hammar as auditor in charge.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexTech Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20261102:BIT:3414:0) on November 02, 2026, and is solely responsible for the information contained therein.